Oncolytics Biotech (NASDAQ:ONCY – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.09) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.09), MarketWatch Earnings reports. During the same period in the prior year, the company earned ($0.07) earnings per share. Oncolytics Biotech Stock Up 0.5 % Shares […]
Oncolytics Biotech Inc. (NASDAQ:ONCY – Get Free Report)’s share price traded down 2.2% during trading on Thursday . The stock traded as low as $2.24 and last traded at $2.25. 624,567 shares were traded during trading, an increase of 15% from the average session volume of 544,050 shares. The stock had previously closed at $2.30. […]
Oncolytics Biotech Inc. (NASDAQ:ONCY – Get Rating) shares traded up 3.6% during trading on Friday . The company traded as high as $1.72 and last traded at $1.72. 227,457 shares changed hands during trading, an increase of 4% from the average session volume of 218,094 shares. The stock had previously closed at $1.66. Wall Street […]
Oncolytics Biotech Inc. (NASDAQ:ONCY – Get Rating) – Research analysts at HC Wainwright lowered their Q2 2023 earnings estimates for shares of Oncolytics Biotech in a report released on Tuesday, May 9th. HC Wainwright analyst P. Trucchio now anticipates that the company will post earnings per share of ($0.09) for the quarter, down from their […]
Oncolytics Biotech (NASDAQ:ONCY – Get Rating) and Nuvation Bio (NYSE:NUVB – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership. Insider & Institutional Ownership 1.2% of Oncolytics Biotech shares […]